ardelyx
The Director, Pharmaceutics at Ardelyx leads planning and execution of drug product activities across multiple programs, overseeing formulation, process development, tech transfer, and manufacturing for clinical and commercial purposes. This senior role collaborates closely with CMC, supply chain, quality, regulatory, and external partners to ensure product development aligns with business objectives and cGMP standards.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2007
Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines for patients with unmet medical needs in gastrointestinal and cardiorenal diseases. The company markets IBSRELA (tenapanor) for irritable bowel syndrome with constipation (IBS-C) and XPHOZAH for chronic kidney disease with hyperphosphatemia, while also pursuing additional pipeline programs including chronic idiopathic constipation. Headquartered in Northern California, Ardelyx is committed to delivering novel-mechanism therapies that improve outcomes for patients with GI and kidney disorders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ardelyx.
12% above the average for this role
Principal Scientist I, Biologics Drug Product Development
AbbVie
Senior Scientist II, Biologics Drug Product Development
AbbVie
Director, CMC Product Development – Small Molecule
Beeline Medicines
Senior Scientist II, Biologics Drug Product Development
AbbVie
Associate Director, CMC Product Development – Small Molecule
Beeline Medicines
Executive Director, Pharmaceutical Development (Solid Orals)
lifelancer